Error message

The page you requested does not exist. For your convenience, a search was performed using the query events thu 25 jul 0930 micrornas circulating biomarkers cancer.

Search results

  1. Dr Catherine Lindon

    ... role of substrate proteolysis in the precisely coordinated events giving rise to two daughter cells at the end of mitosis. The Aurora ...

  2. Dr Athena Matakidou

    ... modify the mouse renal apithelium and replicate the genetic events observed in human renal cell carcinoma. The development of reproducible ...

  3. Dr Mariann Bienz

    ... cell compartment. Our aim is to understand the molecular events underlying Wnt signal transduction. We focus on positively-acting ...

  4. Dr Dario Bressan

    ... for the spatial and temporal control of biological events in vivo. Specifically, I am using photochemically caged ligands and ...

  5. Dr Frank McCaughan

    My research is focused on understanding the early driver events that are critical to the development of squamous lung cancer (SQC) and ...

  6. Professor Gillian Murphy

    ... by trafficking which allows specific localisation in events such as cell invasion. The identification of the importance of specific ...

  7. Dr James Nathan

    Cellular mechanisms of oxygen and metabolite sensing: ...

  8. Dr James Rudd

    ... arteries as a predictor of plaque rupture and clinical events. Additionally, I use non-invasive imaging methods such as PET, MRI and ...

  9. Ms Paola Marco

    ... The inhibitor can be washed out, allowing us to study events in a more flexible way. I will introduce these mutants in RPE cells to ...

  10. Dr Marisa Segal

    ... morphogenesis in S. cerevisiae we have focused on the events that determine SPB asymmetry or spindle polarity, i.e. the mechanisms ...

  11. Dr David Gilligan

    David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...

  12. Mr David Thurtle

    Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer

  13. Professor David Glover

    Our laboratory studies the regulation of progression through mitosis and meiosis in animal cells. The high degree of evolutionary conservation of these regulatory mechanisms means that findings in model organisms are readily applicable to human cells....

  14. Dr Roisin Owens

    Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...

  15. Mr Thierry Lefebvre

    Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...

  16. Professor Walid Khaled

    My laboratory works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on how the cell of origin affects the differentiation trajectory of nascent tumour cells and dictates changes...

  17. Dr Ali Amin Al Olama

    My research has focused on discovery of genetic risk factors of prostate cancer through genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer Association Group to Investigate...

  18. Mr Arqum Anwar

    Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...

  19. Mrs Abigail Redman

  20. Miss Andrea Martos Esteban

  21. Dr Andrew Gill

    I work in the hyperpolarized-13C imaging group in the Department of Radiology and apply computational methods to the analysis of MR images of tumours. I have in the past specialised in pharmacokinetic modelling of DCE-MRI data. My more recent work...

  22. Dr Andrew Kidger

  23. Miss Anne Christin Machel

  24. Professor Alan Fersht

    -

  25. Dr Arnaud Comment

    Development of hyperpolarization techniques based on dynamic nuclear polarization (DNP) for magnetic resonance spectroscopy and imaging in particular for biomedical applications. My research is focused on three main axes: Methodology in DNP, including...

  26. Dr Ashley Nicholls

  27. Professor Julie Ahringer

    We investigate the functions chromatin regulatory complexes implicated in human disease using the C. elegans model system. These include the histone deacetylase complex NuRD, the Retinoblastoma complex DRM, and a TIP60 histone acetyltransferase complex....

  28. Mr Julius Christopher Baeck

    I am a Wellcome Trust-funded  PhD student  in Klaus Okkenhaug's lab, Department of Pathology, University of Cambridge. My research focuses on the role of the lipid signalling kinase PI3K δ in B cell homoeostasis. I am particularly...

  29. Dr Julia Carmona-Bozo

    My study focuses on imaging Breast cancer by using PET-MRI

  30. Dr Julian Sale

    My lab is interested in the mechanisms that alleviate arrested DNA replication and the impact their loss has on mutagenesis and on the maintenance of epigenetic memory through the recycling of histones during replication. Replication can be arrested by...

  31. Dr Julius Mieszczanek

  32. Dr Julia Wilson

    Cambridge Cancer Centre Executive Committee, Associate Director for Genetics and Genomics

  33. Miss Julia Knight

    Various projects for Lung Cancer research. Main project working on is Mesobank, preforming the quality control for solid tissue collected.

  34. Dr Julia Moreno-Vicente

  35. Miss Júlia Ponte

  36. Dr Juliane Perner

    Application of computational biology approaches to integrate different types of 'omics'-data with a focus on improving our understanding of the molecular biology of Esophageal cancer and Barrett's esophagus.

  37. Professor Eric Miska

    ... of biology. We will concentrate on basic questions on how microRNAs control gene expression. Our approach is multi-facetted, combining ...

  38. Miss Marta Ferraresso

    Understanding the role of underexpressed microRNAs in malignant germ cell tumours ...

  39. Professor Matthew Murray

    ... approved study, investigating non-coding RNAs, including microRNAs (miR-), in malignant germ cell tumours and other childhood cancers. ...

  40. Mr Amit Roshan

    ... research focus is currently exploring the utility of circulating tumour DNA (ctDNA) in early melanoma, and progressing our ...

  41. Dr Emma Beddowes

    Investigating the development and application of circulating free nucleic acids to breast cancer research. ...

  42. Dr Fazlur Rahman Talukdar

    ... a translational research initiative focused on developing circulating tumour DNA (ctDNA) based biomarkers derived from minimally invasive ...

  43. Dr Laura Blackburn

    ... into healthcare. We have a particular interest in circulating tumour DNA technologies and their potential in terms of cancer ... can be viewed here: http://www.phgfoundation.org/research/circulating-tumour-DNA. We found that while some patients were benefiting ...

  44. Dr Lucy Faulkner

    My research looks at epigenetic changes in circulating tumour DNA (ctDNA) for early detection, active surveillence and ...

  45. Dr Meiling Gao

    Circulating biomarkers in breast cancer

  46. Dr Nitzan Rosenfeld

    ... of molecular and genomic technologies. Our focus is on circulating tumour DNA (ctDNA) as a noninvasive modality to assess evolution of ...

  47. Mr Richard Mair

    My research is focused on the interaction between the microenvironment and genome and how this comes to define brain tumours. I am using novel and ...

  48. Mr Samuel White

    ... formalin-fixed paraffin embedded tissue (FFPE) as well as circulating tumour DNA and Germ line DNA from blood samples and processed blood ...

  49. Dr Andrew Pierce

    DNA damage and repair, oncology clinical biomarkers

  50. Dr Anna Piskorz

    ... ovarian cancer (HGSOC). I work on identification of genomic biomarkers that could be applied in clinic as diagnostic, prognostic and predictive biomarkers, helping in better patient stratification, earlier disease ...

  51. Professor Charlotte Coles

    ... radiotherapy in minimal risk women: patient selection using biomarkers – open: 50+ UK centres to date 4. NEO-RT: feasibility study ...

  52. Dr Pippa Corrie

    ... studies focusing on angiogenesis predictive and prognostic biomarkers. Locally, am collaborating with Ultan McDermott, studying gene ...

  53. Dr Dorentina Bexheti

    ... methods for the analysis small molecules and  metabolites/biomarkers in biological matrices, cancer tissues and cells, using different ...

  54. Professor Evis Sala

    ... clinical development and validation of functional imaging biomarkers to rapidly evaluate treatment response using physiologic and ...

  55. Professor Ferdia Gallagher

    ... humans. The focus of this work is to develop new molecular biomarkers for the detection of cancer as well as methods to assess early ...

  56. Professor Fiona Gilbert

    ... I am keen to develop predictive and surrogate response biomarkers using these functional imaging tools with the aim of improved ... new oncological radiotracers which may be valuable as biomarkers for patient care or in drug development. ...

  57. Dr Gaia Schiavon

    ... resistance mechanisms in ER positive breast cancers - Novel biomarkers and study designs in ‘window of opportunity’ ...

  58. Dr Andreas Bender

    ... large amounts of chemical or biological data related to cancer drug discovery you are very welcome to contact me to see in which way I ...

  59. Dr Alejandra Bruna

    ... aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in ... of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the molecular heterogeneity present in primary ...

  60. Professor Antonis Antoniou

    ... component; - the identification and characterisation of cancer risks for genetically susceptible individuals, such as those carrying ...

  61. Dr Alison Dunning

    Work in the Centre for Cancer Genetic Epidemiology "wet lab" involves running very high throughput ... (NGS) studies. We search for genetic risk factors for both cancer susceptibility and treatment-response. In this we collaborate closely ... consortia for breast, ovarian, endometrial and prostate cancer association studies: BCAC http://bcac.ccge.medschl.cam.ac.uk, CIMBA ...

  62. Dr Ashray Gunjur

    ... broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David ... between gut microbiota and outcomes in patients with rare cancer types. ...

  63. Dr Ahsan MEMON

    ... this holographic system was deployed to the study of cancer and stem cell shape regulation and the role of effective membrane ...

  64. Dr Aisling Redmond

    ... She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK Cambridge Institute (with Professor Jason Carroll), ...

  65. Professor Alan Warren

    ... how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome, containing ... it is also important for oncogenesis: a novel class of human cancer predisposition disorder has recently emerged that is caused by mutations ...

Pages